Home    Back

Ok432    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
278Huge lymphatic malformation with cervicofacial lesion2

278. Huge lymphatic malformation with cervicofacial lesion    [ 19 clinical trials,   23 drugs,   (DrugBank: 7 drugs),   5 drug target genes,   62 drug target pathways]
Searched query = "Huge lymphatic malformation with cervicofacial lesion", "Huge lymphatic malformation", "Lymphatic malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 19 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00010452
(ClinicalTrials.gov)		April 20002/2/2001Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic MalformationsTreatment of Cystic Hygroma (Lymphangiomas) in Children- Picibanil(OK432) Sclerotherapy-Multicenter TrialLymphatic MalformationsDrug: picibanilUniversity of IowaNULLCompleted6 Months18 YearsBoth150Phase 2;Phase 3United States
2NCT03427619
(ClinicalTrials.gov)		January 1, 199810/1/2018OK432 (Picibanil) in the Treatment of Lymphatic MalformationsOK432 (Picibanil) in the Treatment of Lymphatic MalformationsLymphatic MalformationsDrug: OK432Richard JH SmithNULLCompleted6 Months17 YearsAll701Phase 4United States